As the pharmaceutical marketing landscape rapidly evolves, data analytics and artificial intelligence (AI) are driving a new era of targeted, efficient engagement, according to Stephen Onikoro, Chief Operating Officer of PharmaForceIQ. In a recent interview with Fierce, Onikoro emphasized that traditional "spray and pray" tactics are no longer viable, especially with the rise of specialty medications targeting smaller patient populations. He explained that real-world data--when activated in near real-time--enables marketers to reach healthcare providers (HCPs) with highly personalized messages in the critical moments leading up to treatment decisions.
Onikoro also shared how gaps in current omnichannel tools are stifling innovation. Many platforms remain siloed—either locked within pharma company systems or third-party walled gardens—limiting true interoperability. He likened the ideal omnichannel solution to an air traffic controller: independent, connected and agnostic. For Onikoro, the next five years will demand marketers who not only understand their brand but also master data, analytics, and AI. Watch the full interview to learn how PharmaForceIQ is reshaping the future of pharmaceutical marketing—and how your team can prepare for what’s next.
Sponsored
Pharma
Pharma marketing’s future hinges on data, AI, and precision, says PharmaForceIQ COO
The editorial staff had no role in this post's creation.